BioBasque and the Basque BioCluster
Cristina Oyón
Breakout Session: Clusters and smart specialisation strategies: design a...
From the different theoretical ways
of smart diversification, could the
radical foundation of a science
based new industri...
The BioRegion
The Strategy
• First strategy specifically designed (2001-2002) to promote life
sciences in Spain
• Aim: to develop a new ...
The Ecosystem
The Research Subsystem
Micro-nano-bio convergence
The Research Subsystem
The Molecular Imaging Facility
The Health Subsystem
The Health Subsystem
DEMOTEK: medical
devices effectiveness
demonstration unit
The Innovation
Support
Subsystem
The Technology Transfer
Process
The Business Evolution
now
2001
The Government Support
Source: The Basque Country Competitiveness Report, 2013 - Orkestra
The Budget
Rough figures of public
investment in 2012
Knowledge
generation
~20 M€
Sector dynamisation
~0,5 M€
Business
dev...
The Outcome
18
Service Provision
Diagnostics
Therapeutics
Other
Antigens, antibodies one-stop shop
Early drug discovery in-vivo
Food, ...
The Outcome
BioBasque is recognized as a BioRegion at national and
international scale. We are the 4th community in Spain
...
The Future
TRANSVERSAL CAPACITIES
• Biosciences
• Nanosciences
• Advanced manufacturing
MARKETS
• Movility & Transport
• D...
Cristina Oyón
Head of Strategic Initiatives, SPRI
cristina@spri.es
biobasque@spri.es
www.biobasque.org
TCI 2013 BioBasque and the Basque BioCluster
TCI 2013 BioBasque and the Basque BioCluster
Upcoming SlideShare
Loading in …5
×

TCI 2013 BioBasque and the Basque BioCluster

381 views

Published on

By Cristina Oyón, SPRI - Basque Government, presented at the 16th TCI Global Conference, Kolding 2013.

Published in: Technology, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
381
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
7
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

TCI 2013 BioBasque and the Basque BioCluster

  1. 1. BioBasque and the Basque BioCluster Cristina Oyón Breakout Session: Clusters and smart specialisation strategies: design and implementation 5 September 2013
  2. 2. From the different theoretical ways of smart diversification, could the radical foundation of a science based new industrial activity be a sound lever for productive transformation? Source: The Basque Country Competitiveness Report, 2013 - Orkestra The Question
  3. 3. The BioRegion
  4. 4. The Strategy • First strategy specifically designed (2001-2002) to promote life sciences in Spain • Aim: to develop a new business sector in the Basque Country reated to biosciences • Integrated approach built around three axis: knowledge generation, business development, dynamisation • Mission: to establish a biocluster capable of competing internationall • Cuantitative objectives: 40 new companies, 3.000 new jobs • Chosen as RegioStars 2011 Awards (EU) finalist, among 66 initiatives from 18 countries, awards to most innovative regional projects which have received funding from the EU regional/ cohesion policy
  5. 5. The Ecosystem
  6. 6. The Research Subsystem Micro-nano-bio convergence
  7. 7. The Research Subsystem The Molecular Imaging Facility
  8. 8. The Health Subsystem
  9. 9. The Health Subsystem DEMOTEK: medical devices effectiveness demonstration unit
  10. 10. The Innovation Support Subsystem
  11. 11. The Technology Transfer Process
  12. 12. The Business Evolution now 2001
  13. 13. The Government Support Source: The Basque Country Competitiveness Report, 2013 - Orkestra
  14. 14. The Budget Rough figures of public investment in 2012 Knowledge generation ~20 M€ Sector dynamisation ~0,5 M€ Business development ~5 M€
  15. 15. The Outcome
  16. 16. 18 Service Provision Diagnostics Therapeutics Other Antigens, antibodies one-stop shop Early drug discovery in-vivo Food, environmental safetyDrug development services Drug screening & analysis Clean labs, bio-safety Engineers and consultants agri-food Bromatology lab Drug production support Ophthalmological sanitary products Polymeric dispersion µ-beads Bio-software systems Natural chem. fungicides (crops) Cell-based assays (drug discovery) Metabolomic Dx Vaccines, allergology Drug development (CNS) Regenerative medicine Full-cycle Pharma Tissue engineering, cell therapy Biotech cosmetics Nanomedicines (biocompatible nanoparticles) Drug development, distribution Non-invasive Dx (ophthalmology ) Genetic Dx methods Genomic IVD tests In-vitro Dx tests Dx & Tp animal health The Outcome
  17. 17. The Outcome BioBasque is recognized as a BioRegion at national and international scale. We are the 4th community in Spain regarding nr of biotechs, accounting for the 9%, well above the 6% of Spanish GDP that supposes the Basque economy. In 2007-2011 the nr of biotechs has been multiplied by 1,4. The sector employs directly 1.600 persons in R&D, representing 5,8% of total employment in R&D. The R&D personnel accounts for the 50% of total employment The sector invoices more than 300 M€. 57% of biotechs have increased its invoicing in the period 2007-2011. 31% have maintained it. 60% of biotechs are less than 10 years old. 90% of them are internationalized
  18. 18. The Future TRANSVERSAL CAPACITIES • Biosciences • Nanosciences • Advanced manufacturing MARKETS • Movility & Transport • Digital World • Science Industry • Ageing / Health • Energy Bio-Nano Sciences Smart Manufacturing Energy EXISTING PRIORIZITATION (PCTI 2015) REFLECTION PROCESS META PRIORITIES REFLECTION PROCESS PILOT PROJECTS Source: The Basque Country Competitiveness Report, 2013 - Orkestra
  19. 19. Cristina Oyón Head of Strategic Initiatives, SPRI cristina@spri.es biobasque@spri.es www.biobasque.org

×